| Name | Title | Contact Details |
|---|
Kolltan Pharmaceuticals is a private company founded in 2007 that is developing novel monoclonal antibody (mAb) drugs targeting receptor tyrosine kinases (RTKs). Kolltan's primary targets derive from seminal discoveries made in the laboratory of Dr. Joseph Schlessinger, Chairman of the Department of Pharmacology at the Yale School of Medicine, and in Kolltan’s laboratories. Dr. Schlessinger's laboratory has characterized a novel molecular mechanism underlying activation of RTKs providing, for the first time, a clear molecular explanation — at atomic resolution — for the oncogenic activity of mutations that have been identified in a variety of human cancers.
CanReg, Inc. is a Mississauga, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Cirtec Medical Systems is a Los Gatos, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Copies - FYI is a Lenexa, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Orlando Senior Health Network is a network of companies that provides a broad range of residential living options, home care and rehabilitation services, plus pharmaceutical and medical equipment offerings, designed to improve the quality of life for s...